Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01518335 · ClinicalTrials.gov registry record · NA
Use of Platelet Rich Plasma Therapy for Acute Ankle Sprains in the Emergency Department
A NA study, sponsored by Albert Einstein Healthcare Network.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT01518335 is a NA study that has completed, run by Albert Einstein Healthcare Network. The registered enrollment target is 38 participants.
The verdict
NCT01518335, a NA study, has completed, sponsored by Albert Einstein Healthcare Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
This research study hopes to determine whether or not platelet rich plasma therapy improves healing time of moderate to severe ankle sprain in comparison to standard of care therapy.
Interventions
- PROCEDURE Platelet rich plasma injection
- PROCEDURE Placebo Comparator: Placebo/Standard of Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01518335
The ClinicalTrials.gov registry entry for NCT01518335 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein Healthcare Network, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Platelet rich plasma injection is the first listed.
NCT01518335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01518335 about?
NCT01518335 is a clinical study titled "Use of Platelet Rich Plasma Therapy for Acute Ankle Sprains in the Emergency Department". This research study hopes to determine whether or not platelet rich plasma therapy improves healing time of moderate to severe ankle sprain in comparison to standard of care therapy.
What is the current status of trial NCT01518335?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2009-06. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01518335?
The interventions under investigation include: Platelet rich plasma injection (PROCEDURE), Placebo Comparator: Placebo/Standard of Care (PROCEDURE).
Who is sponsoring clinical trial NCT01518335?
This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.